Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Over the last 12 months, insiders at Leap Therapeutics, Inc. have bought $0 and sold $0 worth of Leap Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Leap Therapeutics, Inc. have bought $5.37M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,543,800 shares for transaction amount of $7.25M was made by BeiGene, Ltd. (10 percent owner) on 2021‑09‑24.
2021-09-24 | BeiGene, Ltd. | 10 percent owner | 2.54M 2.5963% | $2.85 | $7.25M | -50.98% | ||
2020-06-22 | PERCEPTIVE ADVISORS LLC | 10 percent owner | 1.75M 3.2241% | $2.00 | $3.5M | -5.56% | ||
2019-02-05 | HealthCare Ventures IX, L.P. | 10 percent owner | 1.14M 7.6323% | $1.85 | $2.11M | +7.64% | ||
2019-02-05 | ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 1.14M 7.6323% | $1.85 | $2.11M | +7.64% | ||
2019-02-05 | Mirabelli Christopher | CEO, President, Chairman | 1.14M 7.2197% | $1.75 | $2M | +7.64% | ||
2019-02-05 | LAWLOR AUGUSTINE | Chief Operating Officer | 1.14M 7.6323% | $1.85 | $2.11M | +7.64% | ||
2017-11-14 | ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 2.12M 19.7866% | $6.08 | $12.87M | +16.41% | ||
2017-11-14 | Mirabelli Christopher | CEO, President, COB | 2.12M 19.7866% | $6.08 | $12.87M | +16.41% | ||
2017-11-14 | LAWLOR AUGUSTINE | Chief Operating Officer | 2.12M 19.7866% | $6.08 | $12.87M | +16.41% | ||
2017-11-14 | HealthCare Ventures IX, L.P. | 10 percent owner | 2.12M 19.7866% | $6.08 | $12.87M | +16.41% |
PERCEPTIVE ADVISORS LLC | 10 percent owner | 8476496 33.1561% | $1.76 | 1 | 0 | <0.0001% |
BeiGene, Ltd. | 10 percent owner | 7348437 28.7437% | $1.76 | 1 | 0 | <0.0001% |
HealthCare Ventures IX, L.P. | 10 percent owner | 4144804 16.2126% | $1.76 | 2 | 0 | +12.03% |
ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 4114804 16.0952% | $1.76 | 2 | 0 | +12.03% |
LAWLOR AUGUSTINE | Chief Operating Officer | 4114804 16.0952% | $1.76 | 2 | 0 | +12.03% |
Mirabelli Christopher | CEO, President, Chairman | 4114804 16.0952% | $1.76 | 2 | 0 | +12.03% |
Baker Bros Advisors LP | $3.12M | 3.06 | 1.17M | 0% | +$0 | 0.04 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $2.43M | 2.38 | 911,937 | +9.48% | +$210,139.96 | 0.06 | |
The Vanguard Group | $2.31M | 2.27 | 867,708 | +111.74% | +$1.22M | <0.0001 | |
Citadel Advisors LLC | $1.89M | 1.86 | 711,319 | +4.18% | +$75,996.22 | <0.01 | |
Balyasny Asset Management Llc | $1.78M | 1.75 | 670,543 | New | +$1.78M | 0.01 | |
Samsara Biocapital Llc | $1.78M | 1.75 | 669,303 | 0% | +$0 | 0.28 | |
Adage Capital Partners Gp L L C | $1.28M | 1.25 | 480,000 | -49.09% | -$1.23M | <0.01 | |
683 Capital Management Llc | $1.2M | 1.18 | 450,000 | 0% | +$0 | 0.13 | |
Simplify Asset Management Inc | $1M | 0.98 | 375,976 | New | +$1M | 0.1 | |
ACUTA CAPITAL PARTNERS LLC | $942,082.00 | 0.93 | 354,166 | 0% | +$0 | 0.61 | |
Acadian Asset Management | $750,000.00 | 0.74 | 282,413 | +349.34% | +$583,090.19 | <0.01 | |
Key Client Fiduciary Advisors Llc | $619,828.00 | 0.61 | 233,018 | New | +$619,828.00 | 0.09 | |
Geode Capital Management | $538,967.00 | 0.53 | 202,572 | -0.68% | -$3,692.94 | <0.0001 | |
Renaissance Technologies | $304,000.00 | 0.3 | 114,470 | +692.18% | +$265,624.88 | <0.0001 | |
Ubs Oconnor Llc | $285,716.00 | 0.28 | 107,412 | -25.2% | -$96,230.85 | 0.02 | |
Dimensional Fund Advisors | $174,541.00 | 0.17 | 65,617 | New | +$174,541.00 | <0.0001 | |
State Street | $168,147.00 | 0.17 | 63,213 | 0% | +$0 | <0.0001 | |
Northern Trust | $120,272.00 | 0.12 | 45,215 | +1.47% | +$1,747.62 | <0.0001 | |
Logos Global Management Lp | $105,070.00 | 0.1 | 39,500 | New | +$105,070.00 | 0.01 | |
Xtx Topco Ltd | $98,941.00 | 0.1 | 37,196 | New | +$98,941.00 | 0.01 | |
Susquehanna International Group | $78,382.00 | 0.08 | 29,467 | -76.9% | -$260,876.11 | <0.0001 | |
BlackRock | $77,933.00 | 0.08 | 29,298 | -69.21% | -$175,183.00 | <0.0001 | |
Squarepoint Ops LLC | $71,873.00 | 0.07 | 27,020 | New | +$71,873.00 | <0.0001 | |
Marshall Wace | $57,626.00 | 0.06 | 21,664 | New | +$57,626.00 | <0.0001 | |
Goldman Sachs | $48,627.00 | 0.05 | 18,281 | New | +$48,627.00 | <0.0001 | |
Millennium Management LLC | $40,320.00 | 0.04 | 15,158 | New | +$40,320.00 | <0.0001 | |
American Century Investments | $28,244.00 | 0.03 | 10,618 | New | +$28,244.00 | <0.0001 | |
Tower Research Capital | $17,468.00 | 0.02 | 6,567 | +113.35% | +$9,280.62 | <0.0001 | |
Advisor Group Holdings Inc | $12,340.00 | 0.01 | 4,639 | -9.73% | -$1,330.03 | <0.0001 | |
Simplex Trading Llc | $6,000.00 | 0.01 | 2,257 | -90.53% | -$57,386.80 | <0.0001 | |
Cibc Private Wealth Group Llc | $4,125.00 | <0.01 | 1,500 | New | +$4,125.00 | <0.0001 | |
CNB Bank | $3,990.00 | <0.01 | 1,500 | 0% | +$0 | <0.01 | |
Morgan Stanley | $2,908.00 | <0.01 | 1,093 | -12.98% | -$433.67 | <0.0001 | |
U.S. Bancorp | $1,623.00 | <0.01 | 610 | 0% | +$0 | <0.0001 | |
Group One Trading | $2,157.00 | <0.01 | 811 | -2.76% | -$61.17 | <0.0001 | |
JPMorgan Chase | $604.00 | <0.01 | 227 | -14.98% | -$106.43 | <0.0001 | |
Qube Research & Technologies | $16.00 | <0.01 | 6 | 0% | +$0 | <0.0001 | |
Wells Fargo | $404.00 | <0.01 | 152 | +2.01% | +$7.97 | <0.0001 | |
Tompkins Financial Corporation | $319.00 | <0.01 | 120 | 0% | +$0 | <0.0001 | |
Caldwell Sutter Capital Inc | $11.00 | <0.01 | 4 | 0% | +$0 | <0.0001 | |
Allworth Financial Lp | $306.00 | <0.01 | 115 | 0% | +$0 | <0.0001 | |
RhumbLine Advisers | $63.00 | <0.01 | 24 | 0% | +$0 | <0.0001 |